SUMMARY Cervical secretions and seminal plasmas from uninfected clinically healthy persons and vaginal exudates from patients with infections other than gonorrhoea converted gonococci susceptible to killing by fresh human serum to resistance after three hours' incubation at 370C. The inducing factors present in the genital secretions explain the serum resistance of gonococci from patients with acute urethritis. This serum resistance is lost on subculture in laboratory media but could play an important role in vivo in the survival of gonococci in the initial stages of urogenital infection when serum factors are liberated into the local infection site during inflammation.
Introduction
Gonococci obtained from infected patients are resistant to killing by human serum. This resistance is accepted as important in the pathogenesis of gonorrhoea in relation to survival in the bloodstream in disseminated infection.' Less attention has been paid to its possible role in local infections of the mucous membranes and subepithelial tissues, where it could be equally important in promoting survival against serum factors which will certainly be liberated into the area by the intense inflammatory response which is evoked by gonococcal infection. A fact sometimes forgotten in the universal acceptance of the serum resistance of strains from disseminated infections2 is that gonococcal strains isolated from urethral pus and examined directly without subculture are also resistant to killing by human serum.3 The latter resistance is, however, different from the former. Whereas most strains from disseminated infections retain their resistance to human serum on subculture many of the isolates from acute urethritis lose their resistance in laboratory cultures.3 We have been interested in this unstable type of resistance-that is, what host factors induce the resistance in vivo that are absent from artificial media. Firstly, using infection of subcutaneously implanted plastic chambers in guinea pigs as a convenient source of serum (human)-resistant gonococci grown in vivo, it was shown that resistance was phenotypically determined4 and induced by factors in guinea pig serum, one of which was of low molecular weight.5 6 Attention then turned to human inducing factors which were found in about 2507. of human sera and in both high and low molecular weight fractions.7 In relation to the induction or maintenance of serum resistance in gonococci at the beginning and early stages of mucosal infection, female and male genital secretions have now been examined for resistanceinducing activity.
Materials and methods

GENITAL SECRETIONS
At Birmingham cervical scrapings were obtained from uninfected, clinically healthy subjects by courtesy of Drs R Condie, K K Chan, R Patel, and H Leung (St Chad's Hospital). Scrapings were collected in saline (5-10 ml) and kept at -20°C until required for tests. After being thawed at 37°C, the samples were sonicated (Rapidis Ultrasonic SP-957, Ultrasonic Ltd, Shipley, Yorks; 50 watts, 20 kHz; four bursts of 30 seconds at room temperature) and centrifuged (2500 x g for 15 minutes at room temperature). The supernatant fluid was separated, filtered through a Millipore membrane (0' 22 Mm pore size), and tested for resistance-inducing activity. In the first instance nine samples were bulked for testing and then subsequent samples were tested individually.
At Birmingham seminal plasma was also collected from uninfected, clinically healthy subjects by 363 courtesy of Mr C J Lodge (St Chad's Hospital) and Mr P J Adams (Selly Oak Hospital). Each sample (about 2 ml) was processed without dilution with saline. They were sonicated, centrifuged, and filtered through a Millipore membrane as described for the cervical secretions. Owing to the high viscosity only 0. 1-0.5 ml of filtered material was available for testing for resistance-inducing activity.
In Paris vaginal exudates were collected by courtesy of Dr F Pean (International Students' Hospital) from 14 clinically infected patients without bacteriologically diagnosed gonorrhoea; the diagnosed infections were viral, one, bacterial other than gonococcal, four, fungal, two, and parasitic, one. All samples (0 2-4 5 ml) contained about 50%o (v/v) cellular debris. After standing at 40C for 3-4 hours the samples were diluted with an equal volume of defined medium (see below) at pH 7 ± 0X2. After vortex mixing and centrifuging (3000 x g for 10 minutes at room temperature) the supernatant fluid was separated, adjusted to pH 6 6 ± 0 2, heated for 40 minutes at 56°C, filtered through Millipore membrane (0-22-gm pore size) and stored at -200C until tested for resistance-inducing activity.
SERUM-SENSITIVE NEISSERIA GONORRHOEAE
This was strain BS4 (agar) derived, stored, cultured, and viably counted as described.578
GENERATION OF RESISTANT ORGANISMS
The method was performed as described. 5 In each experiment a sample of heat-inactivated human serum known to have negligible resistanceinducing activity was included in the system for generation of resistant organisms; the gonococci so produced were shown to be completely susceptible PM VMartin, P VPatel, NJParsons, and HSmith (less than 1% survivors) to killing by fresh human serum in the test system described. Also, in the work with cervical secretions and seminal plasmas samples of small molecular weight fractions from guinea pig serum5 6 known to be active or inactive in inducing resistance were included as additional controls. Finally, the absence of appreciable amounts of inhibitors of bactericidal activiiy (for example, anticomplimentary materials) in the genital secretions was checked by testing the bactericidal activity of FHS against susceptible BS4 (agar) organisms with and without the amount of genital secretion which would have been carried over from the generation of resistant organisms into the bactericidal test.
All samples of genital secretions were tested 2-3 times and typical results are quoted below.
Results
RESISTANCE INDUCTION
By cervical secretions from uninfected clinically healthy women A bulked sample of secretions from nine people consistently converted 50-60% of the susceptible gonococci to resistance. Eleven individual samples of secretions converted 100%, 61%, 601o, 60%, 51%, 48%, 467o, 30%, 26%, 20%, and <10% of susceptible gonococci to resistance. In all these experiments the number of viable gonococci present at the end of the three-hour conversion period was 80-130% of those present initially.
By seminal plasmas from uninfected clinically healthy men In preliminary tests two seminal plasmas both converted 10017. of the susceptible gonococci to resistance. In subsequent tests 10 different seminal plasmas converted 100070, 9707, 9207, 92%, 91%, 91%, 9007, 71%, 60%, and 13% of susceptible gonococci to resistance. Some seminal plasmas had a slight ability to inhibit the bactericidal activity of human serum (see above). With these samples, to make sure that any carry-over of plasma from the conversion mixture did not interfere with the subsequent test for resistance the gonococci were centrifuged (3500 x g for 10 minutes) at the end of the three-hour conversion period and washed twice with 500 jA of DM containing 0 10o bovine serum albumin before subsequent testing. The results of the resistance tests on these washed gonococci were almost identical with those in which the gonococci were not washed. In all these experiments the number of viable gonococci present at the end of the threehour conversion period was 70-200%o of those Induction in gonococci ofphenotypic resistance to killing by human serum by human genitalsecretions 365 present initially. Ten additional samples of seminal plasma showed some toxicity to gonococci when used undiluted in the conversion media but twofoldfourfold dilutions of all samples were not toxic and retained substantial resistance-inducing ability.
By vaginal exudates from patients with infections other than gonorrhoea Two of the samples of vaginal secretions killed all gonococci in the three-hour incubation period probably owing to the presence of antibiotics from local treatment or to the toxic action of materials liberated from the phagocytes of the local inflammatory response. Of the remaining 12 samples, four showed distinct resistance-inducing activity converting 34%, 50%, 67%, and 1007o of the susceptible gonococci to resistance in three hours at 37°C, two had low activity (conversion less than 20%), and the remainder appeared inactive. At the end of the three-hour conversion period for the active samples the number of viable gonococci was 110-230% of those present initially.
Discussion
Genital secretions from both women and men contain factor(s) which render gonococci resistant to killing by human serum, and the presence of these factors explains the serum resistance of gonococci examined directly from patients with acute urethritis.3 The resistance-inducing activity of seminal plasma recalls the demonstration that addition of extract of prostate gland to laboratory media preserved the serum resistance of recent gonococcal isolates.9 In this respect it is interesting that three of the 10 inducer-positive samples of seminal plasma (see results) came from subjects who had had vasectomies. Preliminary ultrafiltration experiments similar to those reported for guinea pig and human serum6 ' indicated that the resistance inducing factor(s) in cervical secretions are present in similar low molecular-weight fractions. 6 It is difficult to believe that the serum resistance of gonococci on and within genital epithelium does not play a role in survival in the initial stages of infection. While it is true that there is no direct evidence that the gonocidal factors in human serum are liberated into the local genital sites during inflammation this almost certainly happens, because there is good reason to believe that the lethal factors are natural antibody and complement which would, without doubt, be mobilised to the site of infection.
In the present study no attempt was made to assess the relative amounts of resistance-inducing factors in the different secretions examined and in the individual samples of each secretion. Clearly, the seminal plasmas were examined in a more concentrated form than the saline extracts of the cervical secretions and the DM-diluted vaginal secretions. In view of the probable importance of the inducing factors in the pathogenesis of gonorrhoea a more comprehensive and quantitative survey of genital secretions from various sources may be warranted. This would be easier to accomplish if the chemical nature of the inducer was known. Work to this end is in progress.
Finally, this study has underlined the fact that most gonococci whether they are causing local or disseminated infection are resistant in vivo to killing by human serum. Hence, the ability of some strains to cause disseminated infection must rely on pathogenic mechanisms in addition to being resistant to killing by human serum.
Our thanks are due to Dr E Boxall, of the East Birmingham Hospital, for checking that all samples of cervical secretions and seminal plasmas were free from hepatitis B virus. 
